Clostridium difficile--a continually evolving and problematic pathogen.
about
Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review16S rRNA gene sequencing and healthy reference ranges for 28 clinically relevant microbial taxa from the human gut microbiome.Comparison of PCR ribotyping and multilocus variable-number tandem-repeat analysis (MLVA) for improved detection of Clostridium difficileThe anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.Characterisation of Clostridium difficile biofilm formation, a role for Spo0A.The safety of drugs used in acid-related disorders and functional gastrointestinal disorders.Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycinColonization of toxigenic Clostridium difficile among ICU patients: a prospective study.Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune responseDiagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.Wall Teichoic Acids Are Involved in the Medium-Induced Loss of Function of the Autolysin CD11 against Clostridium difficile.Coexistence of multiple multilocus variable-number tandem-repeat analysis subtypes of Clostridium difficile PCR ribotype 027 strains within fecal specimens.SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate.Mapping interactions between germinants and Clostridium difficile spores.Effect of the proton pump inhibitor omeprazole on the gastrointestinal bacterial microbiota of healthy dogs.Prevalence of Isolated from Beef and Chicken Meat Products in Turkey
P2860
Q28073805-5265313B-15B4-4700-A183-F8434C0C7191Q33632346-0E528CA7-0427-4073-AB52-27E919073E1CQ34035948-0B9756FB-9B45-45CF-96D0-98D43A7107BBQ34055302-28718E34-64A3-4004-B869-3440C105D23BQ34510386-F0D681E6-9C00-4573-8AD4-BDE351F80BADQ35052602-1F3854A2-9716-4EE8-B47B-D786B8A1AE0BQ35692976-90278FDA-0A1C-43E1-860F-AAFC09B9B6F3Q36099373-2F7A459F-E639-45D8-8A9A-A1CCA9E1C41BQ36119996-26FADEC0-F4A3-4081-A67C-D3BAFDB46EEEQ36320846-FE0409AA-8AF9-4C61-8450-71370B166C5EQ37035829-879C2A08-6827-4355-A0BC-BEBFEC016F0BQ37348810-6EDDF8AF-D5F7-4DD8-AE9C-44BACF20C6FFQ39412163-25AA4E80-1048-49F0-A6B8-2B04EA650D9AQ41948068-C771E6FE-1270-4E7E-ABD0-6E2CA97E2D8FQ42165855-201E5852-D950-458D-9624-BEBAE4BE6DB3Q54324781-05346D2F-8E03-4E88-AFB9-F86922D1FF61Q56624069-6828854C-6FA9-4DBF-B27F-19C4190002D0
P2860
Clostridium difficile--a continually evolving and problematic pathogen.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Clostridium difficile--a continually evolving and problematic pathogen.
@en
type
label
Clostridium difficile--a continually evolving and problematic pathogen.
@en
prefLabel
Clostridium difficile--a continually evolving and problematic pathogen.
@en
P1476
Clostridium difficile--a continually evolving and problematic pathogen.
@en
P2093
Esmeralda Valiente
Lisa F Dawson
P304
P356
10.1016/J.MEEGID.2009.06.005
P577
2009-06-16T00:00:00Z